Moreover, it has been shown that CLEC9A+/BDCA3+ DCs have the dual capacity to produce both IL-12 and type I IFN (34), thereby enabling both NK cell activation and Th1 polarization, which could be significant for a protective immune response against viral infections. Here, CLEC9A is linked to viral infectious disease.